Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-04 RUBINSTEIN JULIE President Sale −6,695 $59.25 $397K 0
2021-02-04 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 35,000
2021-02-03 ROBINS HARLAN S Chief Scientific Officer Option exercise +7,790 $6.32 $49K 8,469
2021-02-03 ROBINS HARLAN S Chief Scientific Officer Sale −6,930 $59.49 $412K 1,539
2021-02-03 ROBINS HARLAN S Chief Scientific Officer Sale −860 $60.34 $52K 679
2021-02-03 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −7,790 186,960
2021-02-03 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2021-02-03 RUBINSTEIN JULIE President Sale −8,655 $59.39 $514K 6,345
2021-02-03 RUBINSTEIN JULIE President Sale −5,435 $60.16 $327K 910
2021-02-03 RUBINSTEIN JULIE President Sale −910 $60.82 $55K 0
2021-02-03 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 50,000
2021-02-02 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2021-02-02 RUBINSTEIN JULIE President Sale −7,710 $58.58 $452K 7,290
2021-02-02 RUBINSTEIN JULIE President Sale −5,280 $59.20 $313K 2,010
2021-02-02 RUBINSTEIN JULIE President Sale −2,010 $59.99 $121K 0
2021-02-02 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 65,000
2021-02-02 ROBINS HARLAN S Chief Scientific Officer Option exercise +7,790 $6.32 $49K 8,469
2021-02-02 ROBINS HARLAN S Chief Scientific Officer Sale −2,910 $58.76 $171K 5,559
2021-02-02 ROBINS HARLAN S Chief Scientific Officer Sale −2,501 $59.80 $150K 3,058
2021-02-02 ROBINS HARLAN S Chief Scientific Officer Sale −2,379 $60.57 $144K 679

Page 63 of 120 · 2,386 trades